Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder

NCT06512389 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: Oral solution

Sponsor

Centre for Addiction and Mental Health